ASTCT HOME MeetingsClinical Education Conference

CLINICAL EDUCATION CONFERENCE

October 22-23, 2026 | Virtual

Registration Is Now Open

About the Conference

The Clinical Education Conference (CEC) provides a deeper understanding of the diagnostic evaluations and therapeutic treatments for acute and chronic complications of hematopoietic cell transplantation and cellular therapies. During this two-day event, participate in breakout sessions that will dig deeper into case studies and treatments of either the adult or pediatric patient populations. In addition, the CEC offers a track specially designed for beginners (defined as at about one year into their careers in the field).

Learning Objectives

Describe the latest trends in the stem cell transplantation and cellular therapy fields.
Incorporate new or additional methods of supportive care to reduce patient complications and improve quality of life.
Identify opportunities to improve your current clinical practice.

Who Should Attend

Advanced practice providers (APPs)
Fellows
In-training professionals
Nurses

Registration

Type	Early Bird Rate (closed)	Regular Rate
Registration Rates
ASTCT Member Rate	$275	$350
Non-Member Rate	$375	$450
Trainee Rate	$225	$300
Low-Middle Income Countries Rate*		$30

*Only eligible for registrants currently practicing and residing in a low-middle income country as classified by the World Bank here.

Agenda

Please note, schedule is subject to change. All times listed are in Central Time. Last update: June 30, 2026. View speaker disclosures.

Day 1: Thursday, October 22

8:00 – 8:15 AM	Housekeeping
8:15 – 8:55 AM	Keynote: Caring For Yourself While Caring For Others Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; Translational Genomics Research Institute (TGen), City of Hope Cancer Center
9:00 – 9:40 AM	Why Patients Miss CAR-T Trials: A Practical Framework for Identifying Eligible Candidates in Clinical Practice Yan Leyfman, MD; New York Presbyterian Hospital
9:45 – 10:25 AM	Quality and Safety in Transplant and Cellular Therapy: A Practical Approach to Improving Outcomes Chris Dandoy, MD, MS; Cincinnati Children's Hospital Medical Center
10:30 – 10:40 AM	Break
10:40 – 11:20 AM	Cord Blood Transplantation in the Modern Era Warren Fingrut, MD, MPH; MD Anderson
11:25 AM – 11:55 PM	GI Toxicities and Nutrition during Allogeneic Stem Cell Transplant Tracy Farrell, PA-C; University of Colorado Anschutz Katie Harper, MS, RD, CNSC, CSO; UC Health
12:05 – 12:50 PM	Product Theater Choosing an Established Treatment Option for Appropriate Patients with cGVHD - presented by Sanofi
12:55 – 1:20 PM	Post Transplant TA-TMA Leonor Perez Aquino, DNP, ApRN-C, AOCNP, TCTCN; Miami Cancer Institute
1:25 – 2:10 PM	Advanced Cellular Therapy for Cancer: CAR T beyond FDA Approval Siddhartha Ganguly, MD, FACP; Houston Methodist Hospital Neal Cancer Center
2:15 – 3:00 PM	Product Theater Is TA-TMA on your Radar? From Clinical Detection to Appropriate Treatment - presented by Omeros
3:05 – 3:45 PM	GVHD Prophylaxis in 2026 - PTCy, Dose Optimization, and Emerging Combination Strategies Nihar Desai, MD, DM; Princess Margaret Cancer Center
3:50 – 4:30 PM	Transforming Therapies for Sickle Cell Disease Anil George, MD; Baylor College of Medicine/Texas Children's Hospital

Day 2: Friday, October 23

Track	Beginner	Adult	Pediatric
8:00 – 8:45 AM	Ethical Issues Inherent in Caring for Stem Cell Transplantation and Cellular Therapy Joyce Neumann, PhD, APRN, AOCN, HEC-C, FAAN; The University of Texas MD Anderson Cancer Center
8:45 – 9:25 AM	Who Gets a Transplant? Disease, Patient and Donor Factors in Allo Transplant Candidacy Charlotte Hughes, MD; Memorial Sloan Kettering Cancer Center	Understanding and Comparing Eligibility for HSCT and CART for Elderly Patients (>70): The Role of Frailty, Functional Trajectories, and T Cell Fitness Marco Ruiz, MD, MPH, MSc, MBA; Miami Cancer Institute/Florida International University	Microbiome, HCT and CAR T Robert Jenq, MD; City of Hope
9:30 – 10:10 AM	Conditioning Regimens Boglarka Gyurkocza, MD; Fred Hutchinson Cancer Center	Immunotherapies in Multiple Myeloma Muhammad Faisal, MD; OU Health Stephenson Cancer Center	Lineage Switch Leukemia: An Emerging Phenomenon in the Era of Immunotherapy Sara Silbert; National Cancer Institute
10:15 – 10:30 AM	Break
10:30 – 11:10 AM	Going Viral: A Timeline of Infection in Transplant Leah Yoke, PA-C, MCHS; Fred Hutchinson Cancer Center	Case Study Review: Infectious Diseases in Hematopoietic Stem Cell Transplant Kristin Lind, APRN-CNP; The Ohio State University	Post-Transplant Vaccinations Paul Carpenter; Fred Hutchinson Cancer Center
11:15 – 11:55 AM	Recognizing and Managing GVHD: A Practical Guide for Clinical Care Doris Ponce, MD, MS; Memorial Sloan Kettering Cancer Center	Beyond Steroids: Updates in Chronic Graft versus Host Disease Brooke Adams, PharmD, BCOP; Orlando Health Cancer Institute	GVHD in Children: Don't Throw Out the Tried and True: Integrating Established and Emerging Therapies Vinita Pai, PharmD, MS, BCPPS; The Ohio State University, College of Pharmacy
12:00 – 1:00 PM	Product Theater: "Individualized Therapy for Advanced Melanoma" presented by Iovance
1:00 – 1:25 PM	CAR T Toxicities Made Practical: A Case-Based Approach to CRS, ICANS, and Delayed Neurotoxicity Basem William, MD, MRCP(UK), FACP; OhioHealth	A Case of Relapsed/Refractory Diffuse Large B-cell Lymphoma: Impact of Prior CAR T-cell Therapy on Subsequent Treatment Lines Grace Li, CRNP, AOCNP; National Cancer Institute	TA-TMA Complicated Case Review Samantha Newman, AC-PNP; University of Michigan
1:30 – 2:15 PM	The Price of Cure: Transplant-Related Organ Toxicity in Hematopoietic Cell Transplantation Sanja Zepcan, PharmD; Loyola University Medical Center	Sexual Health in Adults with Cancer: Assessment, Monitoring, and Management for Healthcare Professionals Daniel Verina, DNP, MSN, RN, ACNP-BC; Mount Sinai Medical Center	Early Recognition and Management of Pediatric VOD/SOS After HCT: From Bedside Warning Signs to Defibrotide Decisions Mayada Shanap, MD; King Hussein Cancer Center
2:15 – 2:30 PM	Break
2:30 – 3:10 PM	CAR T Decoded: Indications, Toxicities, and Real-World Practice Gabriel Sanchez-Pettito, MD; Baylor College of Medicine	Navigating Anti-BCMA CAR T Cell Therapy Toxicities: Recognition, Management, and Future Directions Francesca Cottini, MD; The Ohio State University	Pediatric CAR T Coordination from Referral Through Follow-up Anna Sparrow, PhD, MPH, RN; Children's Hospital of Philadelphia
3:15 – 3:55 PM	HLA Matching in Transplant: What Every Clinician Needs to Know Rajdeep Das, MD, PhD; University Hospitals Cleveland Medical Center	Disease Evaluation and Transplant Strategies for Patients with Myelofibrosis Rachel Salit, MD; Fred Hutchinson Cancer Center	Gene Therapy for Immunodeficiency: Are We There Yet? Sung-Yun Pai, MD; National Cancer Institute
4:00 – 4:30 PM	A Practical Guide to Post-Transplant Maintenance Therapy Olivia White, PharmD, BCOP; UT Southwestern Medical Center	DLI: Past, Present, and Future Emily Bauer, DNP, APRN, AGACNP-BC; University of Chicago Medicine	From Evaluation to Infusion: Managing Psychosocial Complexity Daniel Gaylor; Moffit

Accredited Provider

This activity is jointly provided by The France Foundation in collaboration with the American Society for Transplantation and Cellular Therapy (ASTCT).

ACCREDITATION STATEMENT

In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation

The France Foundation designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

The France Foundation designates this activity for 12.0 contact hours.

All other health care professionals completing this accredited activity may receive a statement of participation.

Sponsorship

If you are interested in sponsoring this event, please contact Angie Dahl at adahl@astct.org.